Effects of heparin fractions on the prevention of skin necrosis resulting from adriamycin extravasation: An experimental study

Basit Öğe Kaydı
dc.contributor.authorAskar, I
dc.contributor.authorErbas, MK
dc.contributor.authorGurlek, A
dc.date.accessioned2024-08-04T20:13:09Z
dc.date.available2024-08-04T20:13:09Z
dc.date.issued2002
dc.departmentİnönü Üniversitesien_US
dc.description.abstractExtravasation of a chemotherapeutic agent is one of the most frequent complications in cancer patients. Full-thickness skin necrosis often occurs after extravasation. Alternative approaches to treatment are local wound care, elevation, and hypothermia. It was shown that heparin prevents skin necrosis. In this experimental study, the effects of heparin fractions on the prevention of skin necrosis were compared by applying an extravasation model of Adriamycin in rats. Forty Sprague-Dawley male rats weighing 250 to 300 g were used. A total of 0.3 ml doxorubicin hydrochloride was administered subcutaneously to all rats. Ten minutes later, in the control group (group 1), 1 ml normal saline was administered subcutaneously. In the first experimental group (group 11), 100 U per day heparin sodium was administered in a volume of 1 ml subcutaneously. In the second experimental group (group III), nadroparin calcium (5 anti-Xa U per kilogram per day) was administered. In the third and last experimental group (group IV), dalteparin sodium (5 anti-Xa U per kilogram per day) was administered. All drugs were administered for 2 weeks. Necrotic areas were measured 4 weeks later. Statistical analysis was performed using the Kruskal-Wallis analysis of variance and the Mann-Whitney U test. Heparin fractions caused a decreased ulcer rate and size than controls (p < 0.05). There was no superiority among heparin fractions. The authors think that low-molecular weight heparins are preferred, considering the higher risk of bleeding with unfractionated heparin.en_US
dc.identifier.doi10.1097/00000637-200209000-00010
dc.identifier.endpage301en_US
dc.identifier.issn0148-7043
dc.identifier.issn1536-3708
dc.identifier.issue3en_US
dc.identifier.pmid12351979en_US
dc.identifier.scopus2-s2.0-0036714349en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage297en_US
dc.identifier.urihttps://doi.org/10.1097/00000637-200209000-00010
dc.identifier.urihttps://hdl.handle.net/11616/93432
dc.identifier.volume49en_US
dc.identifier.wosWOS:000177921600012en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherLippincott Williams & Wilkinsen_US
dc.relation.ispartofAnnals of Plastic Surgeryen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectMolecular-Weight Heparinen_US
dc.subjectTissue Extravasationen_US
dc.titleEffects of heparin fractions on the prevention of skin necrosis resulting from adriamycin extravasation: An experimental studyen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu